Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Effect of dialysis on all trans retinoic acid levels in a child with acute promyelocytic leukemia and renal failure.

Rajpurkar M, Alcasabas P, Warrier I, Valentini RP, Fassinger N, Frattarelli DA, Ravindranath Y

Carman and Ann Adams Department of Pediatrics, Division of Hematology Oncology, Children's Hospital of Michigan, Detroit, Michigan 48201, USA. mrajpurk@med.wayne.edu

All trans retinoic acid (ATRA) combined with chemotherapy has become the mainstay of treatment for patients with acute promyelocytic leukemia (APL). Renal dysfunction (RD) is commonly seen in patients with APL. We describe a patient with APL and multi-organ failure, who was on chronic veno-venous hemofiltration followed by hemodialysis (HD) and later peritoneal dialysis (PD), who received ATRA. ATRA levels were assessed as the body clearance of ATRA in children on HD and/or PD was unknown. Neither HD nor PD significantly affected ATRA levels, suggesting that dose modifications of ATRA may not be necessary for children with these forms of renal replacement therapy.

Published 22 October 2007 in Pediatr Blood Cancer, 49(7): 994-6.
Full-text of this article is available online (may require subscription).

© 2004-2008 Acute Myeloid Leukemia Research Today. All Rights Reserved.